{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:59:38Z","timestamp":1780091978028,"version":"3.54.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":985,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"United Kingdom Primary Immunodeficiency Network"},{"DOI":"10.13039\/100012083","name":"British Society for Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,14]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Common variable immunodeficiency (CVID) represents a heterogeneous group of rare disorders. There is considerable morbidity and mortality as a result of non-infectious complications, and this presents clinicians with management challenges. Clinical guidelines to support the management of CVID are urgently required. The UK Primary Immunodeficiency Network and the British Society for Immunology funded a joint project to address this. A modified Delphi Survey was conducted for the assessment, diagnosis and treatment of the non-infectious blood, respiratory, gut and liver complications of CVID. A steering group of 10 consultant immunologists and one nurse specialist developed and reviewed the survey statements and agreed the final recommendations. In total, 22 recommendations and three areas for research were developed.<\/jats:p>","DOI":"10.1111\/cei.13272","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T13:53:26Z","timestamp":1549461206000},"page":"328-335","source":"Crossref","is-referenced-by-count":21,"title":["British Society for Immunology\/United Kingdom Primary Immunodeficiency Network consensus statement on managing non-infectious complications of common variable immunodeficiency disorders"],"prefix":"10.1093","volume":"196","author":[{"given":"C","family":"Bethune","sequence":"first","affiliation":[{"name":"Peninsula Immunology and Allergy Service, University Hospitals Plymouth, Plymouth"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2654-9881","authenticated-orcid":false,"given":"W","family":"Egner","sequence":"additional","affiliation":[{"name":"Clinical Immunology and Allergy Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8106-0480","authenticated-orcid":false,"given":"T","family":"Garcez","sequence":"additional","affiliation":[{"name":"Immunology Department, Manchester University NHS Trust, Manchester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Huissoon","sequence":"additional","affiliation":[{"name":"West Midlands Immunodeficiency Centre, Birmingham Heartlands Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7394-6804","authenticated-orcid":false,"given":"S","family":"Jolles","sequence":"additional","affiliation":[{"name":"Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Karim","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Allergy, Frimley Park Hospital, Frimley, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, The John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Savic","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Allergy, St James\u2019s University Hospital, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9719-1082","authenticated-orcid":false,"given":"K","family":"Kelley","sequence":"additional","affiliation":[{"name":"National Guideline Centre, Royal College of Physicians, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Grosse-Kreul","sequence":"additional","affiliation":[{"name":"Department of Immunological Medicine, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Grigoriadou","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Royal London Hospital, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,7]]},"reference":[{"key":"2022021406245780900_cei13272-bib-0001","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fimmu.2014.00415","article-title":"Comparison of diagnostic criteria for common variable immunodeficiency disorder","volume":"5","author":"Ameratunga","year":"2014","journal-title":"Front Immunol"},{"key":"2022021406245780900_cei13272-bib-0002","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3906\/sag-1412-108","article-title":"Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up","volume":"46","author":"Caliskaner","year":"2016","journal-title":"Turk J Med Sci"},{"key":"2022021406245780900_cei13272-bib-0003","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/tropej\/fml077","article-title":"Mortality and morbidity in common variable immunodeficiency","volume":"53","author":"Aghamohammadi","year":"2007","journal-title":"J Trop Pediatr"},{"key":"2022021406245780900_cei13272-bib-0004","volume-title":"ESID Registry- Working definitions for clinical diagnosis of PID 2014","author":"European Society for Immunodeficiences"},{"key":"2022021406245780900_cei13272-bib-0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2022021406245780900_cei13272-bib-0006","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaci.2017.05.024","article-title":"Cancer in primary immunodeficiency diseases: cancer incidence in the United States Immune Deficiency Network Registry","volume":"141","author":"Mayor","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 6","key":"2022021406245780900_cei13272-bib-0007","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.anai.2013.06.032","article-title":"Managing comorbid complications in patients with common variable immunodeficiency","volume":"111","author":"Ballow","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2022021406245780900_cei13272-bib-0008","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"2022021406245780900_cei13272-bib-0009","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jaip.2017.01.021","article-title":"Lung Foundation\/United Kingdom primary immunodeficiency network consensus statement on the definition, diagnosis, and management of granulomatous\u2013lymphocytic interstitial lung disease in common variable immunodeficiency disorders","volume":"5","author":"Hurst","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2022021406245780900_cei13272-bib-0010","first-page":"1","article-title":"The Delphi Technique: making sense of consensus","volume":"12","author":"Hsu","year":"2007","journal-title":"Pract Assess Res Eval"},{"key":"2022021406245780900_cei13272-bib-0011","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/bjh.14654","article-title":"Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia","volume":"177","author":"Hill","year":"2017","journal-title":"Br J Haematol"},{"key":"2022021406245780900_cei13272-bib-0012","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2022021406245780900_cei13272-bib-0013","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2022021406245780900_cei13272-bib-0014","volume-title":"Dyspepsia and gastro-oesophageal reflux disease: investigation and management of dyspepsia, symptoms suggestive of gastro-oesophageal reflux disease, or both","author":"National Institute for Health and Care Excellence (NICE)","year":"2014"},{"key":"2022021406245780900_cei13272-bib-0015","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/ajg.2010.214","article-title":"The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease","volume":"105","author":"Malamut","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2022021406245780900_cei13272-bib-0016","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/19325037.2012.10599216","article-title":"Advantages and limitations of the e-Delphi technique: implications for health education researchers","volume":"43","author":"Donohoe","year":"2012","journal-title":"Am J Health Educ"},{"key":"2022021406245780900_cei13272-bib-0017","volume-title":"STILPAD Study of interstitial lung disease in patients with primary antibody deficiency (DRKS-ID: DRKS00000799)"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.13272","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.13272","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.13272","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/196\/3\/328\/42506992\/cei13272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/196\/3\/328\/42506992\/cei13272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T06:26:40Z","timestamp":1644820000000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/196\/3\/328\/6402516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,7]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,7]]},"published-print":{"date-parts":[[2019,5,14]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13272","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,3,7]]}}}